| Year |
Citation |
Score |
| 2017 |
Gandhi AV, Thipsay P, Kirthivasan B, Squillante E. Adsorption onto Mesoporous Silica Using Supercritical Fluid Technology Improves Dissolution Rate of Carbamazepine-a Poorly Soluble Compound. Aaps Pharmscitech. PMID 28534299 DOI: 10.1208/S12249-017-0784-3 |
0.438 |
|
| 2016 |
Gupta P, Jani KA, Yang DH, Sadoqi M, Squillante E, Chen ZS. Revisiting the role of nanoparticles as modulators of drug resistance and metabolism in cancer. Expert Opinion On Drug Metabolism & Toxicology. PMID 26799671 DOI: 10.1517/17425255.2016.1145655 |
0.38 |
|
| 2014 |
Bommana MM, Kirthivasan B, Shikhar A, Gupta SS, Squillante E. In vivo brain microdialysis as a formulation-screening tool for a poorly soluble centrally acting drug. Drug Development and Industrial Pharmacy. 40: 74-9. PMID 23298323 DOI: 10.3109/03639045.2012.746361 |
0.747 |
|
| 2013 |
Ye Z, Squillante E. The development and scale-up of biodegradable polymeric nanoparticles loaded with ibuprofen Colloids and Surfaces a: Physicochemical and Engineering Aspects. 422: 75-80. DOI: 10.1016/J.Colsurfa.2013.01.016 |
0.462 |
|
| 2012 |
Bommana MM, Kirthivasan B, Squillante E. In vivo brain microdialysis to evaluate FITC-dextran encapsulated immunopegylated nanoparticles. Drug Delivery. 19: 298-306. PMID 22928708 DOI: 10.3109/10717544.2012.714812 |
0.763 |
|
| 2012 |
Kirthivasan B, Singh D, Bommana MM, Raut SL, Squillante E, Sadoqi M. Active brain targeting of a fluorescent P-gp substrate using polymeric magnetic nanocarrier system. Nanotechnology. 23: 255102. PMID 22652439 DOI: 10.1088/0957-4484/23/25/255102 |
0.761 |
|
| 2012 |
Kirthivasan B, Singh D, Raut SL, Bommana MM, Squillante E, Sadoqi M. Targeted polymeric magnetic nanoparticles for brain imaging Proceedings of Spie. 8233. DOI: 10.1117/12.914655 |
0.766 |
|
| 2011 |
Shikhar A, Bommana MM, Gupta SS, Squillante E. Formulation development of Carbamazepine–Nicotinamide co-crystals complexed with γ-cyclodextrin using supercritical fluid process The Journal of Supercritical Fluids. 55: 1070-1078. DOI: 10.1016/J.Supflu.2010.09.009 |
0.72 |
|
| 2010 |
Raut SL, Kirthivasan B, Bommana MM, Squillante E, Sadoqi M. The formulation, characterization and in vivo evaluation of a magnetic carrier for brain delivery of NIR dye. Nanotechnology. 21: 395102. PMID 20820096 DOI: 10.1088/0957-4484/21/39/395102 |
0.775 |
|
| 2010 |
Parikh T, Bommana MM, Squillante E. Efficacy of surface charge in targeting pegylated nanoparticles of sulpiride to the brain. European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft FüR Pharmazeutische Verfahrenstechnik E.V. 74: 442-50. PMID 19941957 DOI: 10.1016/J.Ejpb.2009.11.001 |
0.752 |
|
| 2007 |
Rao R, Squillante E, Kim KH. Lipid-based cochleates: a promising formulation platform for oral and parenteral delivery of therapeutic agents. Critical Reviews in Therapeutic Drug Carrier Systems. 24: 41-61. PMID 17430099 DOI: 10.1615/Critrevtherdrugcarriersyst.V24.I1.20 |
0.402 |
|
| 2004 |
Sethia S, Squillante E. In vitro-in vivo evaluation of supercritical processed solid dispersions: permeability and viability assessment in Caco-2 cells. Journal of Pharmaceutical Sciences. 93: 2985-93. PMID 15468328 DOI: 10.1002/Jps.20199 |
0.743 |
|
| 2004 |
Sethia S, Squillante E. Solid dispersion of carbamazepine in PVP K30 by conventional solvent evaporation and supercritical methods. International Journal of Pharmaceutics. 272: 1-10. PMID 15019063 DOI: 10.1016/J.Ijpharm.2003.11.025 |
0.731 |
|
| 2003 |
Sethia S, Squillante E. Solid dispersions: revival with greater possibilities and applications in oral drug delivery. Critical Reviews in Therapeutic Drug Carrier Systems. 20: 215-47. PMID 14584524 DOI: 10.1615/Critrevtherdrugcarriersyst.V20.I23.40 |
0.741 |
|
| 2003 |
Squillante E, Morshed G, Bagchi S, Mehta KA. Microencapsulation of β-galactosidase with Eudragit L-100 Journal of Microencapsulation. 20: 153-167. DOI: 10.3109/02652040309178058 |
0.309 |
|
| 2002 |
Sethia S, Squillante E. Physicochemical characterization of solid dispersions of carbamazepine formulated by supercritical carbon dioxide and conventional solvent evaporation method. Journal of Pharmaceutical Sciences. 91: 1948-57. PMID 12210042 DOI: 10.1002/Jps.10186 |
0.738 |
|
| 1997 |
Squillante E, Needham T, Zia H. Solubility and in vitro transdermal permeation of nifedipine International Journal of Pharmaceutics. 159: 171-180. DOI: 10.1016/S0378-5173(97)00282-2 |
0.312 |
|
| Show low-probability matches. |